Skip to main content
Skip to primary sidebar
Search
Aphios
Inspired by Nature, Enabled by Science®
Products
▼
Enhanced Therapeutic Products Overview
Therapeutic Products Pipeline
▼
Oncology
▼
Zindol®
APH-0701
APH-0911
APH-0912
APH-0804
Taxosomes™
Camposomes™
Dermos™
APH-0201
Sperol™
Infectious Disease
▼
APH-0812
APH-0202
nanoHYP™
Asterias™
Marinus™
HIV/AIDS Therapeutic Vaccine
Anti-HIV Therapeutics
Anti-Influenza Therapeutics
Vaccine Adjuvant Technology
▼
Anthrax Vaccine Adjuvant
CNS Disorders
▼
APH-1104
Xantol™
APH-0802 – nanoTHC™
APH-1403
Diabetes
▼
APH-0907
Research Chemicals & API’s
▼
Adhyperforin
Adhyperforin DCHA
Betulin
Betulinic Acid
Bryostatin 1
Bryostatin 2
Bryostatin 3
Camptothecin
C-ATR
Cephalomannine
Cyclopamine
Cycloposine
10-DAB
9-DHAB
Δ9-THC
Δ9-THCA
Frondoside A
6-Gingerol
8-Gingerol
10-Gingerol
Hypericin
Hyperforin
Hyperforin DCHA
Jervine
MLA
Muldamine
Nobiletin
Paclitaxel
Phloridzin Dihydrate
Sclareolide
6-Shogaol
Tangeretin
Veratramine
Equipment
Quality of Life Medicines
Technology
▼
Enabling Technology Platforms
Drug Discovery
Drug Manufacturing
Drug Delivery
▼
CFN
PNS
PNP
Drug Safety
▼
CFI™ Mechanisms of Action & Applications
Microbial Cell Disruption
Crystallization
▼
Natural Therapeutics Crystallization – CRY
SuperFluids Crystallization Process
Biomass Pretreatment
▼
Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
Partnering
▼
Partnering Overview
▼
Zindol LLC
Pharmaceutical & Biotechnology Partners
University Partners
Institutional Research Partners
Investors
▼
Investors Overview
▼
Aphios Pharma LLC
Aphios International LLC
Resources
▼
Resources Overview
Facilities
Intellectual Property
Marine Microorganism Library
Research Grants & Contracts
About
▼
Company Overview
Management & Directors
Scientific Advisory Board
Community Involvement
Press Releases
Events
Careers
Contact
Shop
Products
Enhanced Therapeutic Products Overview
Therapeutic Products Pipeline
Oncology
Zindol®
APH-0701
APH-0911
APH-0912
APH-0804
Taxosomes™
Camposomes™
Dermos™
APH-0201
Sperol™
Infectious Disease
APH-0812
APH-0202
nanoHYP™
Asterias™
Marinus™
HIV/AIDS Therapeutic Vaccine
Anti-HIV Therapeutics
Anti-Influenza Therapeutics
Vaccine Adjuvant Technology
Anthrax Vaccine Adjuvant
CNS Disorders
APH-1104
Xantol™
APH-0802 – nanoTHC™
APH-1403
Diabetes
APH-0907
Research Chemicals & API’s
Adhyperforin
Adhyperforin DCHA
Betulin
Betulinic Acid
Bryostatin 1
Bryostatin 2
Bryostatin 3
Camptothecin
C-ATR
Cephalomannine
Cyclopamine
Cycloposine
10-DAB
9-DHAB
Δ9-THC
Δ9-THCA
Frondoside A
6-Gingerol
8-Gingerol
10-Gingerol
Hypericin
Hyperforin
Hyperforin DCHA
Jervine
MLA
Muldamine
Nobiletin
Paclitaxel
Phloridzin Dihydrate
Sclareolide
6-Shogaol
Tangeretin
Veratramine
Equipment
Quality of Life Medicines
Technology
Enabling Technology Platforms
Drug Discovery
Drug Manufacturing
Drug Delivery
CFN
PNS
PNP
Drug Safety
CFI™ Mechanisms of Action & Applications
Microbial Cell Disruption
Crystallization
Natural Therapeutics Crystallization – CRY
SuperFluids Crystallization Process
Biomass Pretreatment
Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
Partnering
Partnering Overview
Zindol LLC
Pharmaceutical & Biotechnology Partners
University Partners
Institutional Research Partners
Investors
Investors Overview
Aphios Pharma LLC
Aphios International LLC
Resources
Resources Overview
Facilities
Intellectual Property
Marine Microorganism Library
Research Grants & Contracts
About
Company Overview
Management & Directors
Scientific Advisory Board
Community Involvement
Press Releases
Events
Careers
Contact
Shop
Aphios Granted Chinese Patent for Novel Bryoid to Treat Alzheimers Disease
Aphios Granted Chinese Patent for Novel Bryoid to Treat Alzheimers Disease